Comparison of survival rate in primary non-small-cell lung cancer among elderly patients treated with radiofrequency ablation, surgery, or chemotherapy

CardioVascular and Interventional Radiology

Volumn 35, Issue 2, 2012, Pages 343-350

  Lee, Heon ^a   Jin, Gong Yong ^b   Han, Young Min ^b   Chung, Gyung Ho ^b   Lee, Yong Chul ^b   Kwon, Keun Sang ^b   Lynch, David ^c  

^a Seoul Medical Center   (South Korea)

^b Chonbuk National University Medical School   (South Korea)

^c DEPARTMENT OF MEDICINE   (United States)

Author keywords

Lung; Radiofrequency ablation; Tumor

Indexed keywords

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER CHEMOTHERAPY; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; COMPARATIVE STUDY; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FUNCTIONAL ASSESSMENT; GERIATRIC PATIENT; HUMAN; KAPLAN MEIER METHOD; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PATIENT ASSESSMENT; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; RETROSPECTIVE STUDY; SURVIVAL RATE; SURVIVAL TIME; TREATMENT CONTRAINDICATION;

ADENOCARCINOMA; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; CASE-CONTROL STUDIES; CATHETER ABLATION; COMBINED MODALITY THERAPY; FEMALE; HEPATECTOMY; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; RETROSPECTIVE STUDIES; SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 84862886461     PISSN: 01741551     EISSN: 1432086X     Source Type: Journal    
DOI: 10.1007/s00270-011-0194-y     Document Type: Article

References (25)

1. Gillams A (2009) Tumor ablation: current role in the liver, kidney, lung and bone. Cancer Imaging 2 (9): 68-70
2. Rose SC (2008) Radiofrequency ablation of pulmonary malignancies. Semin Respir Crit Care Med 29 (4): 361-383
3. Hiraki T, Gobara H, Mimura H et al. (2008) Percuteneous radiofrequency ablation of lung cancer. Lancet Oncol 97 (7): 604-605
4. Jin GY, Lee JM, Lee YC et al. (2004) Primary and secondary lung malignancies treated with percutaneous radiofrequency ablation: evaluation with follow-up helical CT. AJR Am J Roentgenol 183 (4): 1013-1020
5. Nguyen CL, Scott WJ, Young NA et al. (2005) Radiofrequency ablation of primary lung cancer: results from an ablate and resect pilot study. Chest 128 (5): 3507-3511
6. Jin GY, Han YM, Lee YS et al. (2008) Radiofrequency ablation using a monopolar wet electrode for the treatment of inoperable non-small cell lung cancer: a preliminary report. Korean J Radiol 9 (2): 140-147
7. VanSonnenberg E, Shankar S, Morrison PR et al. (2005) Radiofrequency ablation of thoracic lesions. Part
8. Initial clinical experience-technical and multidisciplinary considerations in 30 patients. AJR Am J Roentgenol 184 (2): 381-390
9. Steinke K, King J, Glenn D et al. (2004) Percutaneous imagingguided radiofrequency ablation in patients with colorectal pulmonary metastases: 1-year follow-up. Ann Surg Oncol 11 (2): 207-212
10. Lee JM, Jin GY, Goldberg SN et al. (2004) Percutaneous radiofrequency ablation for inoperable non-small cell lung cancer and metastases: preliminary report. Radiology 230 (1): 125-134
11. Dupuy DE, Mayo-Smith WW, Abbott GF, DiPetrillo T (2002) Clinical application of radio-frequency tumor ablation in the thorax. Radiographics 22: S259-S269
12. Gandhi NS, Dupuy DE (2005) Image-guided radiofrequency ablation as a new treatment option for patients with lung cancer. Semin Roentgenol 40 (2): 171-181
13. Jain SK, Dupuy DE, Cardarelli GA et al. (2003) Percutaneous radiofrequency ablation of pulmonary malignancies: combined treatment with brachytherapy. AJR Am J Roentgenol 181 (3): 711-715
14. Kelekis AD, Thanos L, Mylona S et al. (2006) Percutaneous radiofrequency ablation of lung tumors with expandable needle electrodes: current status. Eur Radiol 16 (11): 2471-2482
15. Steinke K, Sewell PE, Dupuy D et al. (2004) Pulmonary radiofrequency ablation an international study survey. Anticancer Res 24 (1): 339-343
16. Lencioni R, Crocetti L, Cioni R et al. (2008) Response to radiofrequency ablation of pulmonary tumors: a prospective, intentionto- treat, multicentre clinical trial (the RAPTURE study). Lancet Oncol 9 (7): 631-638
17. Goldberg SN, Grassi CJ, Cardella JF et al. (2005) Image-guided tumor ablation: standardization of terminology and reporting criteria. Radiology 235 (3): 728-739
18. Stinchcombe TE, Choi J, Schell MJ et al. (2006) Carboplatinbased chemotherapy in patients with advanced non-small cell lung cancer and a poor performance status. Lung Cancer 51 (2): 237-243
19. Robert F, Blumenschein G, Herbst RS et al. (2005) Phase I/IIa study of cetuximab with gemcitabine plus carboplatin in patients with chemotherapy-naive advanced non-small-cell lung cancer. J Clin Oncol 20 (23): 9089-9096
20. Yan TD, King J, Sjarif A et al. (2006) Percutaneous radiofrequency ablation of pulmonary metastases from colorectal carcinoma: prognostic determinants for survival. Ann Surg Oncol 13 (11): 1529-1537
21. Lencioni R, Crocetti L, Cioni R et al. (2004) Radiofrequency ablation of lung malignancies: Where do we stand? Cardiovasc Intervent Radiol 27 (6): 581-590
22. El-Sherif A, Luketich JD, Landreneau RJ et al. (2005) New therapeutic approaches for early stage non-small cell lung cancer. Surg Oncol 14 (1): 27-32
23. Zemlyak A, Moore WH, Bilfinger TV (2010) Comparison of survival after sublobar resections and ablative therapies for stage I non-small cell lung cancer. J Am Coll Surg 211 (1): 68-72
24. Tamiya A, Naito T, Ono A et al. (2010, June 4) Evaluation of the efficacy and safety of chemotherapy for patients with wet stage IIIB/IV non-small-cell lung cancer aged 80 years old or more. Lung Cancer [Epub ahead of print]
25. Chua TC, Thornbury K, Saxena A et al. (2010) Radiofrequency ablation as an adjunct to systemic chemotherapy for colorectal pulmonary metastases. Cancer 116 (9): 2106-2114